Which has the lower trailing P/E, GMED or HSIC?

GMED has the lower trailing P/E: GMED trades at 21.22 and HSIC at 26.35. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GMED or HSIC?

Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus HSIC at 2.71%.

Is GMED or HSIC more profitable?

GMED runs the higher net margin — GMED at 17.03% versus HSIC at 2.96%.

How have GMED and HSIC total returns compared?

Over the past 10 years, GMED delivered 13.76% and HSIC delivered 3.50% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs Henry Schein, Inc. (HSIC)

A side-by-side comparison of Globus Medical, Inc. and Henry Schein, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$11.13B

$82.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

HSIC

Henry Schein, Inc.

$10.28B

$90.28HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — GMED vs HSIC

growth of $100 · dividends reinvested · last 10y

GMED +264.3% (+13.8%/yr)HSIC +43.6% (+3.7%/yr)GMED compounded faster over this window

GMED HSIC

GMED vs HSIC: by the numbers

•GMED is the larger company ($11.13B vs $10.28B market cap).
•GMED trades at the lower trailing earnings multiple (21.22 vs 26.35 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 2.96% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 2.71% CAGR).

Metrics side by side

Valuation

Metric	GMED	HSIC
P/E ratio	21.22	26.35
Forward P/E	16.57	16.79
P/S ratio	3.63	0.76
P/B ratio	2.39	3.27
EV / EBITDA	11.79	12.87
FCF yield	6.58%	5.21%

Profitability

Metric	GMED	HSIC
Gross margin	68.55%	30.31%
Operating margin	20.75%	5.69%
Net margin	17.03%	2.96%
ROE	11.23%	12.77%
ROIC	10.49%	6.53%

Growth (annualized)

Metric	GMED	HSIC
Revenue CAGR (5Y)	27.65%	2.71%
EPS CAGR (5Y)	30.79%	3.14%
FCF CAGR (5Y)	29.93%	0.82%
Total return CAGR (5Y)	0.22%	4.04%

Frequently asked

Which has the lower trailing P/E, GMED or HSIC?: GMED has the lower trailing P/E: GMED trades at 21.22 and HSIC at 26.35. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GMED or HSIC?: Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus HSIC at 2.71%.
Is GMED or HSIC more profitable?: GMED runs the higher net margin — GMED at 17.03% versus HSIC at 2.96%.
How have GMED and HSIC total returns compared?: Over the past 10 years, GMED delivered 13.76% and HSIC delivered 3.50% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full HSIC analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Henry Schein P/E ratio Globus Medical ROE Henry Schein ROE Globus Medical operating margin Henry Schein operating margin Globus Medical revenue growth Henry Schein revenue growth Globus Medical free cash flow Henry Schein free cash flow

Globus Medical & Henry Schein appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.